PheCheck™ Validation Study
Start Date
8/20/2026
Completion Date
4/20/2027
Summary
The goal of this observational study is to evaluate the performance of the PheCheck™ test for the rapid detection of phenylalanine (Phe) from a fingerstick sample, in patients 1 year or older with phenylketonuria (PKU) or hyperphenylalaninemia. The main objective is comparing the concentration of phenylalanine (Phe) in capillary blood with the reference method (DBS).
Detailed Description
The primary objective of this study is to evaluate the performance of the PheCheck™ test for the rapid, quantitative detection of phenylalanine (Phe) direct from a capillary (fingerstick) sample. Results will be compared to reference testing from Dried Blood Spot Cards (DBS). The PheCheck™ test performs a quantitative determination of phenylalanine in a self-collected or parent/guardian-collected capillary blood sample. The analysis will evaluate the performance of the analyte concentration of phenylalanine in prospectively collected samples self-collected and tested by patients with PKU, measured by the PheCheck™ test as compared to the standard of care DBS testing performed by a reference lab
Eligibility Criteria
Age Range: 1 years to No maximum
Interventions
PheCheck
Dried Blood Spot Cards.
Conditions
Locations
Lurie Children's Hospital
Chicago, Illinois 60611
United States
Boston Children's Hospital
Boston, Massachusetts 02115
United States